MCQ: Neonatal sepsis | Antibiotic | Management | Neonatology

MCQ: Neonatal sepsis | Antibiotics | Management

A 3-day-old term neonate develops poor feeding, lethargy, respiratory distress, and temperature instability. The mother had prolonged rupture of membranes for 22 hours and intrapartum fever. Septic shock is suspected. Blood cultures are obtained before antibiotics are started. Which empirical antimicrobial regimen is most appropriate while awaiting culture results?

A. Ampicillin plus gentamicin
B. Cefotaxime plus vancomycin
C. Meropenem alone
D. Piperacillin–tazobactam plus amikacin
E. Vancomycin plus cefepime

Correct answer & Explanation:

Correct Answer

A. Ampicillin plus gentamicin

Explanation: Neonatal sepsis

This neonate has early-onset neonatal sepsis (EOS), occurring within the first 72 hours of life. Major maternal risk factors include prolonged rupture of membranes (>18 hours) and maternal intrapartum fever, while neonatal manifestations include poor feeding, lethargy, respiratory distress, temperature instability, and signs of septic shock.

The most common pathogens causing EOS are:

  • Group B Streptococcus (GBS)
  • Escherichia coli
  • Listeria monocytogenes (less common but important)

The recommended empirical treatment for EOS is ampicillin plus gentamicin. Ampicillin provides coverage against GBS, Listeria, and susceptible Enterococcus species, while gentamicin offers excellent Gram-negative coverage, including E. coli. This combination remains the recommended first-line regimen in most neonatal guidelines.

Why the other options are incorrect

B. Cefotaxime plus vancomycin
Not recommended as routine initial therapy for EOS. Cefotaxime should be reserved for selected situations (e.g., suspected meningitis when lumbar puncture cannot be performed initially). Routine use is associated with increased antimicrobial resistance and invasive candidiasis.

C. Meropenem alone
Reserved for suspected infections with multidrug-resistant Gram-negative organisms or when culture results indicate resistant pathogens. It is not appropriate as first-line empirical therapy.

D. Piperacillin–tazobactam plus amikacin
May be considered in selected NICUs with specific resistance patterns or healthcare-associated infections but is not the standard initial regimen for community-acquired EOS.

E. Vancomycin plus cefepime
Appropriate only when there is strong suspicion of methicillin-resistant Staphylococcus aureus (MRSA) or late-onset hospital-acquired sepsis. It is not recommended for routine EOS.

Key Learning Point

Ampicillin plus gentamicin remains the first-line empirical antibiotic regimen for early-onset neonatal sepsis because it provides appropriate coverage against the most common pathogens while minimizing unnecessary use of broad-spectrum antibiotics.

References

  • Nelson Textbook of Pediatrics, 22nd Edition.
  • American Academy of Pediatrics. Red Book: 2024–2027 Report of the Committee on Infectious Diseases.
  • World Health Organization (WHO). Managing Possible Serious Bacterial Infection in Young Infants.
Scroll to Top